In vitro and in vivo efficacies of amlodipine against Listeria monocytogenes
Listeria monocytogenes causes suppurative gastritis in BALB/c mice. We investigated the effect of the antihypertensive drug amlodipine (Aml) on the growth of L. monocytogenes in vitro and in vivo. Aml showed noteworthy inhibitory action (minimum inhibitory concentration, MIC90 32 µg/ml) against Listeria strains and demonstrated cidal (minimum bactericidal concentration, MBC 64 µg/ml) activity. Aml administered orally at 2.5 µg/g in female BALB/c mice for 7 days, commencing 4 days before oral challenge (1 × 108 CFU/ml with L. monocytogenes ATCC 51774), significantly reduced bacterial counts in the stomach (P < 0.01), liver (P < 0.01), and spleen (P < 0.05), and decreased (P < 0.05) gastric lesions, neutrophilic infiltration, edema, vascular degeneration, and necrosis of gastric tissues. It caused the down-regulation of expression of inflammatory cytokines (IFN-γ, IL-1β, and TNF-α) compared to drug-free control. Aml may be used in the presence of an antibiotic as adjunct therapy that boosts the host immunity against Listeria. Further, QSAR studies might contribute in manipulating it as a lead compound for the synthesis of new, more effective non-antibiotics (helper compounds), perhaps devoid of side-effects, that could be recommended as compassionate therapy for listeriosis.
KeywordsMinimum Inhibitory Concentration Amlodipine Listeria Monocytogenes Minimum Bactericidal Concentration Listeriosis
- 1.Schlech WF (2000) Epidemiology and clinical manifestations of Listeria monocytogenes infections. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds) Gram-positive pathogens. ASM Press, Washington, DCGoogle Scholar
- 2.Dutta NK, Annadurai S, Mazumdar K, Dastidar SG, Kristiansen JE, Molnar J, Martins M, Amaral L (2007) Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium. Int J Antimicrob Agents 30(3):242–249. doi: 10.1016/j.ijantimicag.2007.04.018 PubMedCrossRefGoogle Scholar
- 3.Martins M, Dastidar SG, Fanning S, Kristiansen JE, Molnar J, Pagès JM, Schelz Z, Spengler G, Viveiros M, Amaral L (2008) Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicro Agents 31:198–208CrossRefGoogle Scholar
- 7.Park JH, Kim DJ, Park YH, Seok SH, Cho SA, Baek MW, Lee HY, Park JH (2004) Characteristics of the gastritis induced by Listeria monocytogenes in mice: microbiology, histopathology, and mRNA expression of inflammatory mediators with time course of infection. Microb Pathog 37:87–94. doi: 10.1016/j.micpath.2004.05.002 PubMedCrossRefGoogle Scholar